Gene editing for high Lp(a) should be approached with caution, favoring pharmacological interventions like antisense oligonucleotide inhibitors.

“should we just get rid of LPA genes well maybe but then to your point we have anti sensolo nucleotide Inhibitors that are just around the corner that effectively will get rid of LP little a so why would we risk try erate this from po when we just you a drug that does the same thing with fewer side effects and less permanence”